References
1. Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional
estimates of preeclampsia and eclampsia: a systematic review. Eur
J Obstet Gynecol Reprod Biol. 2013 ; 170 , S. 1-7.
2. Magee LA, van Dadelszen P. State-of-the-art diagnosis and treatment
of hypertension in pregnancy. Mayo Clin Proc. 2018 ; 93 ,
11, S. 1664-1677.
3. Tranquilli AL, Dekker G, Magee L, et al. The classification,
diagnosis and management of the hypertensive disorders of pregnancy: A
revised statement from the ISSHP. Pregnancy Hypertens. 4, 2014, S.
97-104.
4. Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease.Journal of hepatology 2016 ; 64 , S. 933-945.
5. Liu J, Ghaziani TT, Wolf JL. Acute fatty liver disease of pregnancy:
Updates in pathogenesis, diagnosis and management. AM J
Gastroenterology 2017 , S. 838-846.
6. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Preeclampsia.Lancet 2010 ;. 376 , 9741, S. 631-44.
7. Nelson DB, Byrne JJ, Cunningham GF. Acute fatty liver of pregnancy.Clinical Obstetrics and Gynecology 2020 ; 63 , 1, S.
e152-164.
8. Churchill D, Duley L, Thornton JG, Moussa M, Ali HS, Walker KF.
Interventionist versus expectant care for severe pre-eclampsia between
24 and 34 weeks’ gestation. Cochrane Database Syst Rev. 2018 Oct
5;10
9. Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy:
Updates in Pathogenesis, Diagnosis and Management. Am J Obstet Gynecol.
209, 2013, 456, S. e451-457.
10. Minakami H, Morikawa M, Yamada T, Yamada T, Akaishi R, Nishida R.
Differentiation of acute fatty liver of pregnancy from syndrome of
hemolysis, elevated liver enzymes and low platelet counts. J. Obstet.
Gynaecol. Res. 03 2014, 40, S. 641–649.
11. Knight M, Nelson-Piercy C, Kurinczuk J, Spark P, Brocklehurst P, UK
Obstetric Surveillance System. A prospective national study of acute
fatty liver of pregnancy in the UK. Gut 2008 , 57 , S.
251-256.
12. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble
fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial
dysfunction, hypertension, and proteinuria in preeclampsia. J Clin
Invest. 2003 ; 111 , S. 649-658.
13 Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H,
Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H. The
sFlt-1/PlGF Ratio in Different Types of Hypertensive Pregnancy Disorders
and Its Prognostic Potential in Preeclamptic Patients. Am J Obstet
Gynecol 2012 ; 206 (1):58.e1-8
14. Zeisler H, Llurba E, Chantraine F, Vatish M et al. Predictive Value
of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. The New
England journal of medicine. 374, 2016, S. 13-22.
15. Enengl S, Mayer RB, Le Renard PE, Shebl O, Arzt W, Oppelt P.
Retrospective evaluation of established cut-off values for the
sFlt-1/PlGF ratio for predicting imminent delivery in preeclampsia
patients. Pregnancy Hypertens. 2020 ; 19 :143-149.
16. Suzuki H, Nagayama S, Hirashima C, et al. Markedly higher
sFlt-1/PlGF ratio in a woman with acute fatty liver of pregnancy
compared with HELLP syndrom. J. Obstet. Gynaecol. Res. 45, 01 2019, 1,
S. 96-103.
17. Neuman RI, Hesselink ERM, Saleh S, van den Meiracker AV, Danser AHJ,
Visser W Angiogenic Markers Are Elevated in Women With Acute Fatty Liver
of Pregnancy Ultrasound Obstet Gynecol 2019 , 4
18. Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM. The
definition of severe and early-onset preeclampsia. Statements from the
International Society for the Study of Hypertension in Pregnancy.Pregnancy Hypertens. 2013 ; 44-47.
19. Hypertensive Prgnancy Disorders: Diagnosis and Therapy. Guideline of
the German Society of Gynecology and Obstetrics (S2k-Level,
AWMF-Registry No. 015/018, March 2019)
20. Barker ED, McAuliffe FM, Alderdice F, et al. The role of growth
trajectories in classifying fetal growth restriction. Obstet
Gynecol 2013 ; 122 , S. 248-254.
21. Broere-Brown ZA, Schalekamp-Timmermans S, Jaddoe VWV, Steegers EAP.
Fetal Growth and Placental Growth Factor Umbilical Cord Blood Levels.Fetal Diagn Ther. 2018 ; 43 , 26-33.
22. Minakami H, Morikawa M, Yamada T, Yamada T, Akaishi R, Nishida R.
Differentiation of acute fatty liver of pregnancy from syndrome of
hemolysis, elevated liver enzymes and low platelet counts. J.
Obstet. Gynaecol. Res. 2014 ; 40 , S. 641–649.
23. Salcedo MX, Sanz-Cameno P, Medina J, et al. Association between
angiogenesis soluble factors and disease progression markers in chronic
hepatitis C patients. Rev Esp Enferm Dig. 2005 ; 97 , 10.
FIGURE LEGEND
Figure 1: sFlt-1 serum levels in patients with HELLP syndromes or AFLP
Figure 2: PLGF serum levels in patients with HELLP syndromes or AFLP
Figure 3: sFlt-1/PLGF-ratio of patients with HELLP syndromes or AFLP
TABLE: Clinical characteristics of the study population